Trials / Conditions / Stage IVA Uterine Corpus Cancer

Stage IVA Uterine Corpus Cancer

9 registered clinical trials studyying Stage IVA Uterine Corpus Cancer.

Status	Trial	Sponsor	Phase
Completed	Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668	Rutgers, The State University of New Jersey	N/A
Completed	Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed NCT02501954	Women's Cancer Care Associates, LLC	Phase 3
Terminated	Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC- NCT02112552	Albert Einstein College of Medicine	Phase 2
Completed	Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors NCT02575872	Albert Einstein College of Medicine	N/A
Completed	Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820	Roswell Park Cancer Institute	Phase 1
Completed	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126	National Cancer Institute (NCI)	Phase 2
Terminated	Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer NCT01041027	Albert Einstein College of Medicine	Phase 2
Completed	Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persi NCT00729586	National Cancer Institute (NCI)	Phase 2
Completed	Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV En NCT00575952	Gynecologic Oncology Group	Phase 1